Prot# NU 99H11: A Phase I Trial Combining IDEC-Y2B8 and High-Dose Beam Chemotherapy with Hematopoietic Progenitor Cell Transplant in Patients with Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (Study No. 131-I01)

Project: Research project

Project Details

StatusFinished
Effective start/end date6/16/00 → 1/1/11

Funding

  • IDEC Pharmaceuticals Corporation (NU 99H11)